1. Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients. (July 2022) Authors: Raje, Noopur; Medhekar, Rohan; Panjabi, Sumeet; Hines, Dionne M; Wang, Xin; Iskander, Karim; Welliver, Tim; Wade, Rolin L; Ailawadhi, Sikander Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 5(2022) Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗